CD276 and cervical carcinoma: Moreover, we used SBCS-expanded cells to prepare the B7-H3-specific chimeric antigen receptor T cells (B7-H3 CAR-T cells), and evaluated the tumor-killing effect of B7-H3 CAR-T cells against head and neck cancer cell (HNC) line FaDu and cervical cancer cell line Hela.